Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Demant A/S is a Danish company that operates in the healthcare industry, primarily focusing on hearing health. The company designs, develops, and manufactures hearing aids, audiometric equipment, and personal communication devices. Established in 1904, Demant has grown to become a globally recognized player in the hearing healthcare sector. Headquartered in Smørum, Denmark, Demant's products and services are available worldwide through a network of subsidiaries and distributors. The company is noted for integrating advanced technology into its offerings, allowing for improved user experiences and health outcomes. Its strategic position is strengthened by a continuous focus on innovation and a comprehensive product portfolio that caters to various aspects of hearing health.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Demant A/SEli Lilly
Last price
kr 359.60$1,273.46
Currency
DKK
USD
kr 76B$1.1T
47.0642.75
kr 7.64$29.79
0.760.45
0$6.69
00.54%
Sector
HealthHealth
Employees
26,61650,000
Ticker
DKr DEMANT$LLY
Primary listing
CSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in DKrDEMANT or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.